An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Clinical trial NCT07371663 · RECRUITING

Trial details

NCT number: NCT07371663
Sponsor: Beijing Tide Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Cancers NSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer Endometrial Cancer Malignant Melanoma

Start date: 2025-12-03
Primary completion: 2028-09-30
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.